ICAD INC. - COMMON STOCK

iCAD Reports Financial Results for Third Quarter Ended September 30, 2023

13 ноя 2023 16:01:00 Источник Nasdaq GlobeNewswire

iCAD to Report Third Quarter 2023 Financial Results on November 13, 2023

30 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire

iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta

23 окт 2023 08:01:00 Источник Nasdaq GlobeNewswire

Health Canada Grants Device License for iCAD's ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment

16 авг 2023 08:00:00 Источник Nasdaq GlobeNewswire

iCAD Reports Financial Results for Second Quarter Ended June 30, 2023 

14 авг 2023 16:01:00 Источник Nasdaq GlobeNewswire

iCAD and Google Health Expand Integration of Google’s AI Technology with iCAD’s ProFound Breast Health Suite for 2D Mammography for Use as Independent Reader

14 авг 2023 08:00:00 Источник Nasdaq GlobeNewswire

iCAD to Report Second Quarter 2023 Financial Results on August 14, 2023

31 июл 2023 08:00:00 Источник Nasdaq GlobeNewswire

iCAD Signs Strategic Commercial Agreement with Radiology Partners, the Nation’s Largest Radiology Practice

18 июл 2023 08:00:01 Источник Nasdaq GlobeNewswire

iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Cleveland Clinic

12 июл 2023 08:00:00 Источник Nasdaq GlobeNewswire

iCAD Offers ROI Analysis Based on Real-World Results from its ProFound Breast AI Suite at AHRA Annual Meeting

10 июл 2023 08:00:00 Источник Nasdaq GlobeNewswire

iCAD’s ProFound AI Breast Suite Wins U.S. General Services Administration’s AI Healthcare Challenge Award

18 май 2023 08:00:00 Источник Nasdaq GlobeNewswire

iCAD Reports Financial Results for First Quarter Ended March 31, 2023

15 май 2023 16:01:00 Источник Nasdaq GlobeNewswire

New Long-Term Real-World Research Confirms Xoft Skin eBx is as Safe and Effective as Mohs Surgery

11 май 2023 08:00:01 Источник Nasdaq GlobeNewswire

iCAD Showcases Breast AI Suite at Society of Breast Imaging Symposium, World’s Largest Breast Imaging Conference

03 май 2023 08:00:01 Источник Nasdaq GlobeNewswire

iCAD to Report First Quarter 2023 Financial Results on May 15, 2023

01 май 2023 08:00:02 Источник Nasdaq GlobeNewswire

iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Boca Raton Regional Hospital

25 апр 2023 08:00:01 Источник Nasdaq GlobeNewswire

New and Real-World Clinical Evidence Confirms ProFound AI Increases Cancer Detection without Increasing the Rate of Recalls and Reveals Critical Clues to Inform Clinical Decisions

20 апр 2023 08:00:01 Источник Nasdaq GlobeNewswire

iCAD Strengthens Leadership Team with Appointment of Chief Financial Officer and New Senior Executives

17 апр 2023 08:00:01 Источник Nasdaq GlobeNewswire

ProFound AI Risk Outperforms Traditional, Widely-Accepted Breast Cancer Risk Models for Both Short-term and Long-term Risk Assessments

04 апр 2023 08:00:01 Источник Nasdaq GlobeNewswire

iCAD Reports Financial Results for Fourth Quarter ended December 31, 2022 and Year End

28 мар 2023 16:01:00 Источник Nasdaq GlobeNewswire